[ad_1] SILVER SPRING, Md., Oct. 7, 2024 /PRNewswire/ — Today, the U.S. Food and Drug Administration granted marketing authorization for the Healgen Rapid Check COVID-19/Flu A&B Antigen Test. The test, authorized for use without a prescription, […]
Tag: U.S. Food and Drug Administration
FDA Roundup: October 4, 2024
[ad_1] SILVER SPRING, Md., Oct. 4, 2024 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Monday, Oct. 7, the Science Board to the […]
FDA Roundup: October 1, 2024
[ad_1] SILVER SPRING, Md., Oct. 1, 2024 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA announced seven new clinical trial grants […]
FDA Roundup: September 27, 2024
[ad_1] SILVER SPRING, Md., Sept. 27, 2024 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Thursday, the FDA updated the Mycotoxins in […]
FDA Approves Drug with New Mechanism of Action for Treatment of Schizophrenia
[ad_1] SILVER SPRING, Md., Sept. 26, 2024 /PRNewswire/ — Today, the U.S. Food and Drug Administration approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults. It is the […]
